Previous 10 | Next 10 |
2024-04-22 16:01:53 ET Read the full article on Seeking Alpha For further details see: Moderna stock closes in green after eight sessions of losses
CAMBRIDGE, MA / ACCESSWIRE / April 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil (Ministério da Saúde) to supply its mRNA COVID-19 vaccine as an integral part of Brazil's 2024 national vaccination campaign against COVID-19. ...
2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...
2024-04-19 14:50:04 ET Moderna ( NASDAQ: MRNA ) shares are trading in the red on Friday, on track for the eighth consecutive day of losses. Stock down 1.28% at $100.70.... Read the full article on Seeking Alpha For further details see: Moderna stock on track for the ...
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024 to report its first quarter 2024 financial results, and provide a corporate update. A live webcast of the call...
2024-04-15 13:13:02 ET Paramount Global ( NASDAQ: PARA ), Etsy ( NASDAQ: ETSY ) and Albemarle ( NYSE: ALB ) were the most shorted companies among S&P 500 stocks at the end of March (based on short interest as a percentage of outstanding shares float).... Re...
2024-04-14 05:55:00 ET The bull market is roaring higher, and many growth stocks have led the gains -- but this doesn't mean your opportunity to buy growth stocks for a good price is over. Plenty of players with great long-term prospects haven't yet benefited from this favorable market envi...
2024-04-12 13:17:44 ET Short percentage in S&P 500’s healthcare companies surged in the end of March from February, as the life science tools and services sub-sector saw a jump in short interest from the previous month.... Read the full article on Seeking Alpha For fu...
2024-04-12 08:45:00 ET According to some new data revealed by Moderna (NASDAQ: MRNA) at the American Association for Cancer Research Annual Meeting on April 8, the biotech responsible for the Spikevax coronavirus vaccine may have another blockbuster drug in the works, this time a pe...
2024-04-11 10:25:50 ET Summary Among their more prominent programs, Moderna is developing a vaccine-based treatment for solid tumors. Moderna's personalized neoantigen vaccine, mRNA-4157, has shown promising results in clinical trials for melanoma, and some preliminary activity in...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...